P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine
P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine have?
P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine has 0 citations in the OpenAlex counts ScholarIQ stores.
When was P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine published?
P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine has 2022 year in the ScholarIQ index.
What is the open-access status of P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine?
P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine has bronze oa status in the ScholarIQ index.
What is the DOI of P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine?
The DOI for P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine is on the source record.
What is the OpenAlex record for P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine?
The OpenAlex for P10 Evaluating the Correlation between Monthly Migraine Days and Quality-of-Life: Utility Analyses to Inform a Japanese Cost-Effectiveness Model for Fremanezumab in Migraine is on the source record.